lexisnexis whitepaper

Download whitepaper – Pharmaceutical & Life sciences: Third Party Due Diligence

Whitepaper by LexisNexis Few industries are as exposed to risk as the pharmaceuticals and life sciences. It is no longer enough to carry out basic checks alone on third-parties. Companies must engage in enhanced due diligence if they are to avoid the large fines and regulatory penalties. Effective third-party due diligence is increasingly recognized as a strategic driver for sustainable …

algorics whitepaper

Is risk based monitoring (RBM) an opportunity or challenge for mid-size CROs?

Abby Abraham, Vice-President – Clinical Solutions Nicholas Hargaden, President October 2015 www.algorics.com The adoption of risk based monitoring (RBM) in sponsored clinical trials has been driven by both regulators and industry bodies such as Transcelerate and Metrics Champion Consortium (MCC). Amongst the larger pharmaceutical companies and CROs, significant pilot programs have been completed and in some cases a broader roll …

MMM and Oracle webcast

Applying Technologies Across the End-to-End PV Process to Increase Compliance and Quality

29 Oct 2015 Andrew Rut, Chief Executive Officer, MyMeds&Me Michael Braun-Boghos, Director of Safety Analytics, Oracle Health Sciences Safe Harbor Statement The following is intended to outline MyMeds&Me and Oracle Health Sciences  general product direction. It is intended for information purposes only, and may not be incorporated into any contract. It is not a commitment to deliver any material, code, or …

Model N whitepaper

Five Critical Success Factors to Achieve Global Pricing Excellence in Life Sciences

2015 Annual Survey – Global Pricing in Life Sciences By Model N and High Point Solutions “The $US300 billion pharmaceuticals industry is undergoing a profound transformation. Cost containment initiatives by payers, governments and healthcare insurance organizations have created a challenging business environment with controlled pricing, promotion of generic alternatives and greater obstacles to bringing innovative drugs to market. With changing dynamics in the industry, achieving …

Sparking innovation with suppliers

WHITEPAPER by: Giles Breault, Principal and co-founder of The Beyond Group. Sammy Rashed, Principal and co-founder of The Beyond Group.  For some time now we have been delving into the question of what procurement teams imagine themselves becoming. The question may seem sophomoric on the surface but there are plenty of indicators that the same old results will no longer earn you a seat …

Tulane University – Rebuilding a Research Powerhouse

Ahead of BioData World Congress we wanted to share some examples of where high-performance computing is having a real and meaningful impact on scientific research. Tulane University needed to create a new high-performance (HPC) infrastructure following the devastation of Hurricane Katrina. Technology from Intel and Dell brings an all-in-one cluster solution to Tulane, helping them to achieve extraordinary work across …

Elsevier whitepaper

Meeting pharmacovigilance and medical device post-market surveillance requirements

Elsevier R&D Solutions for Pharma and Life Science: extracts from Elsevier’s whitepaper  THE FUNDAMENTALS OF MONITORING LITERATURE Monitoring literature for product citations would be an impossible task if not for modern research informatics solutions. Corporate, academic and government pharmaceutical and medical research facilities produce in excess of 20 terabytes of data per day. Even with only a fraction of this data …

Download Whitepaper: Functionality of silicone oil-free syringe system

Download whitepaper: Functional Evaluation and Characterization of a Newly Developed Silicone Oil-Free Prefillable Syringe System Paper Abstract:  The functionality of a newly developed silicone oil-free (SOF) syringe system, of which the plunger stopper is coated by a novel coating technology (i-coating™), was assessed. By scanning electron microscopy observations and other analysis, it was confirmed that the plunger stopper surface was uniformly …

TGen/Dell/Intel collaboration optimizes genomic sequencing

Ahead of BioData World Congress we wanted to share some examples of where high-performance computing is having a real and meaningful impact on scientific research. With ‘From Bench to Bedside’ as its motto, TGen launched in June 2002 and today anchors a rising biosciences hub in Phoenix, Arizona. The non-profit institute is at the forefront of efforts to bring next-generation …

quality control, QA, quality assurance, QA, QC, manufacturing, efficiency

Download: QA, QC practices in manufacturing to ensure efficiency & quality

Dr Pradeep Nagalkar, Head Quality Control (Bio. & Chem.), Haffkine Bio-Pharma. Corp. Ltd., Mumbai gave a presentation on QA, QC Practices in Manufacturing to Ensure Efficiency & Quality at BioPharma India Convention 2014. Download the presentation to learn: What is Quality Control Importance of Quality Control in Biopharmaceutical Industry Advantages of Quality Control What is Quality Assurance (QA) What is the difference between …